Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
Figure 8
Geometric mean titers and seropositivity rates measured by ELISA for anti-HPV-18, by serostatus in women 16–26 years [129]. ATP cohort for immunogenicity. Bars show log10 geometric mean titer and 95% confidence interval. % = proportion of women seropositive for antigen. For the GMT calculation, seronegative women were assigned a value of half the assay cut-off level. The number of women with evaluable blood sample shows the number of women who were seropositive or seronegative at baseline. ATP: according to protocol; HPV: human papillomavirus; GMT: geometric mean titer.
